Wellspect HealthCare Establishes Strategic Advisory Board, Appoints Two Members
Wellspect HealthCare has formed a strategic advisory board to support its future growth. Paul Moraviec and Michael Frazzette have been appointed as external members.
Wellspect HealthCare, a global provider of medical devices for bladder and bowel dysfunction, has established a new strategic advisory board to support its next phase of growth.
The board includes two new external advisors, Paul Moraviec and Michael Frazzette. Both bring extensive experience in global MedTech, urology, commercial growth, and healthcare leadership.
Moraviec has over 30 years of experience in leadership positions within the medical technology sector, having served as CEO for multiple companies. Frazzette has a long background in global healthcare and medical devices, with a focus on commercial strategy and development.
As a subsidiary of Dentsply Sirona, Wellspect HealthCare aims for significant international expansion. The new advisory board is expected to provide valuable insights and guidance for the company's strategic initiatives.